This report describes a miniaturized size exclusion chromatography column that effectively preseparates raw samples for medical point-of-care testing ͑POCT͒ devices. The minicolumn is constructed of polydimethylsiloxane fabricated on a glass slide. The minicolumn separates 300 ng/ml of beta-human chorionic gonadotropin ͑␤-hCG͒ from an immunoglobulin G ͑IgG͒-rich solution ͑100 g / ml͒ in 7.7 min, with 2.23 resolution and 0.018 mm plate height. The complete analyte discrimination shows potential for the sample preparation stage of POCT devices for cancer screening, prognosis, and monitoring. © 2009 American Institute of Physics. ͓DOI: 10.1063/1.3129871͔ Advances in the diagnostic capabilities of biosensor technology offer increasing opportunities for rapid diagnostic tests without sophisticated laboratory equipments. Point-ofcare testing ͑POCT͒ is an ideal avenue for research, since such devices would marry portability with high sensitivity.
Until recently, biosensor selectivity requirements for this technology have not had the emphasis they deserve. To make POCT technology practicable, the devices must be capable of preparing mixed samples in situ for testing outside the laboratory. 3 This need has motivated us to develop an effective microsized separator suitable for integrating with biosensors on POCT devices: size exclusion chromatography ͑SEC͒ in a miniaturized column.
SEC is a proven method for separating mixed samples based on the size of each analyte using stationary phase particles and isocratic mobile phase. 4 In high performance liquid chromatography ͑HPLC͒, state-of-the-art macrosized SEC columns ͓7.8 mm͑inner diameter͒ ϫ 300 mm͑length͔͒ are packed with 5 m beads to separate various biomolecules. Stationary phase particle pore size determines column separation range and analyte elution order: 4 analytes larger than the pores are excluded and elute first; smaller analytes diffuse into the pores and elute later.
Other miniaturized separators do exist. Huang et al.
5
demonstrated a separation process using laminar flow through horizontally shifted arrays of micrometer-scale obstacles. Particles smaller than one-third of the lane width between neighboring obstacles followed streamlines and were not displaced; larger particles moved into the gap and were displaced from the flow. Shih et al. 6 presented a micro-HPLC chip using parylene and silicon as structural materials and C-18 beads for reverse phase chromatography. The microHPLC chip was integrated with an electrochemical sensor, resistive heater, thermal isolation structures for on-chip chromatography, and a mixture of derivatized amino acid was separated and detected. These successes show that miniaturized columns can separate biomolecules, but neither study used a SEC method.
Cancer biomarkers in serum have been heavily researched, and their importance in every phase of cancer diagnosis, treatment, and monitoring brings interests on sample preparation stage. 7 For example, beta-human chorionic gonadotropin ͑␤-hCG, 22 kDa͒ is a glycoprotein biomarker for testicular and ovarian cancer, and for gestational trophoblastic disease. 8 Conventional methods for monitoring ␤-hCG in human blood are enzyme-linked immunosorbent assay and radioimmunoassay, but both require well equipped laboratory environments and trained technicians.
9,10 A more ideal solution would be POCT devices that can process raw mixed samples quickly, reliably, and inexpensively. In this paper, we present a SEC minicolumn that differentiates ␤-hCG from IgG ͑abundant protein in serum, 150 kDa͒. Separation results are evaluated by fluorescent microscopy.
Resolution determines how well SEC devices separate analytes and performance estimates identify the distance ratio between peak centers and the average peak width of two neighboring peaks. 11 Column efficiency is a performance measure reflecting bandspreading where separation occurs, and plate height ͑H͒ and plate count ͑N͒ are widely used as quantitative measures of chromatographic column efficiency. 11 Plate count is calculated from a single peak in a chromatogram based on the Gaussian model. Plate height is the ratio of the length of the column to plate count and is useful when comparing the efficiencies of two different columns. 11 The stationary phase particle size determines the efficiency, backpressure, and analysis time. 4 Efficiency is a function of particle size: smaller particles result in a smaller plate height and higher efficiency. Backpressure is inversely proportional to column permeability, which is proportional to particle size and therefore, smaller particle causes higher backpressure. Short analysis times require high flow rates that result in increased backpressure. In this work, a flexible biocompatible polymer, polydimethylsiloxane ͑PDMS͒, was used for the structural material for the minicolumn, so backpressure is a limiting design factor. To avoid structural failure from high backpressure, we used a relatively large-sized stationary phase particle ͑5-20 m diameter with 10 nm surface nanopores͒. Figure 1͑a͒ shows a schematic of the SEC minicolumn ͑top and cross-section views͒. The column, stationary phase particle insertion port, and microfluidic channel dimensions ͑width, length, and height͒ are 3 ϫ 5 ϫ 0.02, 0.5ϫ 5 ϫ 0.02, pillars ͑width, length, and height͒ are used as posts to prevent stiction between the column structure and glass substrate. We used replica molding to duplicate a surface pattern on a mold, silicon substrate, and PDMS was used for elastomeric material. 12 Fabricating the silicon mold involves two lithography steps and two deep reactive ion etch steps ͓Fig. 2͑c͔͒. After the PDMS replica and glass side were treated with oxygen plasma, they were bonded together and cured in the oven. A 31 gauge syringe, then, delivered the stationary phase particles at the insertion port using methanol as a solvent and the port was sealed by adhesive. The flexible PDMS structure allows the tapered needle tip to pack the minicolumn without any structural damage. The fabricated prototype appears in ͓Fig. 2͑d͔͒.
␤-hCG and IgG were purchased from USBiological and Invitrogen, and were conjugated with Alexa Fluor 488 ͑green͒ and 594 ͑red͒ from Invitrogen, respectively. The stationary phase particles were purchased from Jordi FLP.
Phosphate-buffered saline ͑PBS͒ from Fisher scientific is the mobile phase.
The experimental setup in Fig. 2͑a͒ shows two syringe pumps ͑Harvard Apparatus͒ delivering the mixed sample and mobile phase to a six-way valve ͑Upchurch͒ that controls sample loading. The PBS flowed into the SEC minicolumn at 1 l / min before 0.2 l of the IgG and ␤-hCG mixture was inserted in the SEC minicolumn. The separated IgG and ␤-hCG were manually collected at 20 s intervals by a 1 l pipette, and checked for fluorescent intensity by an inverted microscope ͑Nikon, TE2000-U͒ with a charge-coupled device camera ͑Photometric͒. The captured fluorescent image was analyzed using ImageJ. 13 Concentrations of ␤-hCG ͑20, 100, 300, and 600 ng/ml͒ and IgG ͑100 g / ml͒ were tested. The ␤-hCG concentration range represents normal ͑20 ng/ml͒ and abnormal conditions ͑above 300 ng/ml͒. The IgG concentration used in the experiment is set by ϳ99% depletion rate from a raw serum sample.
14 Figure 2͑b͒ shows the fluorescent intensity calibration of ␤-hCG. The lowest and highest concentrations showed gray values of 3.00 and 10.00 for ␤-hCG ͑20 and 600 ng/ml͒, and 150 for IgG ͑100 g / ml͒.
Separation results for ␤-hCG ͑300 ng/ml͒ and IgG ͑100 g / ml͒ are shown in Fig. 3͑a͒ . IgG eluted first because of its larger size. Its maximum fluorescent intensity appeared at 3.7 min, with gray value at 92. ␤-hCG began eluting at 6.3 min. Its maximum fluorescent intensity ͑gray value 3.10͒ showed at 7.7 min. Figure 3͑b͒ compares the maximum red and green intensities at 3.7 and 7.7 min. At 3.7 min, IgG showed maximum intensity ͑gray value 92͒, and ␤-hCG showed only the lowest fluorescent intensity ͑gray value 0.02͒. At 7.7 min, on the other hand, ␤-hCG showed maximum intensity ͑gray value 3.10͒, and IgG showed low fluorescent intensity ͑gray value 0.31͒.
Fluorescent intensities of separated IgG and ␤-hCG are lower than the calibration values because the mixed sample is diluted by PBS as it travels through the SEC minicolumn. The minicolumn resolution is calculated by
where ⌬L is the distance between two neighboring peaks and w 1 and w 2 are peak widths. 4,11 A resolution of 2.23 suggests the minicolumn discriminates IgG and ␤-hCG by 99.8%. The plate count, N, and plate height, H, are calculated by
where t R is a retention time, w p is a width of single peak, L is the length of the column, and f is a parameter ͑5.545 with half-height method͒ depending upon the peak width measurement method.
4,11
A plate count of 271.7 corresponds to 0.018 mm plate height in the minicolumn. State-of-the-art macrosized SEC columns have a plate count of 16 000, corresponding to 0.01 875 mm plate height. The comparison indicates that the minicolumn has functionally scaled to ϳ1 / 10 000 of the usual SEC column size, using proportionately less analyte and mobile phase. To determine whether the two column sizes are equally effective, other comparison factors, including reproducibility, injection volume, and column lifetime will need to be considered. 15 These point to avenues for additional research and prototype refinement.
Our results show that the SEC minicolumn separates mixed IgG and ␤-hCG at approximately 71 psi of applied fluidic pressure. The pressure is significantly lower than macrosize counterparts ͑ϳ1000 psi͒ and microsize prior-art ͑ϳ200 psi͒. 7, 16 The lowest ␤-hCG separation concentration is 300 ng/ml, the minimum concentration for abnormal conditions. The minicolumn has a long functional life. We used it repeatedly during the three-month experiment and saw no pore plugging that would result in separation degradation. After each use, the minicolumn was flushed with methanol and stored in a de-ionized water bath.
